Article
Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms.
Pharmacogenomics - 1 Feb 2009
Gupta Meenal, Chauhan Chitra, Bhatnagar Pallav, Gupta Simone, Grover Sandeep, Singh Prashant K, Purushottam Meera, Mukherjee Odity, Jain Sanjeev, Brahmachari Samir K, Kukreti Ritushree
Abstract excerpt
AIM: We investigated 16 polymorphisms from three genes, dopamine receptor D2 (DRD2), catechol-O-methyl transferase (COMT) and brain derived neurotrophic factor (BDNF), which are involved in the dopaminergic pathways, and have been reported to be associated with susceptibility to schizophrenia and response to antipsychotic therapy. MATERIALS & METHODS: Single-locus association analyses of these polymorphisms were...
Topics
- Adult
- Amino Acid Substitution
- Brain-Derived Neurotrophic Factor
- Case-Control Studies
- Catechol O-Methyltransferase
- Exons
- Female
- Genetic Predisposition to Disease
- Genetic Variation
- Humans
